Word: molecular
(lookup in dictionary)
(lookup stats)
Dates: all
Sort By: most recent first
(reverse)
...sets, when allowed (and it almost always is), is routine and often invaluable. Many concentrators want the requirements out of the way so they can explore other courses or their own research.The gem of the department’s course offerings is Chemistry 285, “Human Disease: Molecular Etiology and Mechanistic Pharmacology,” a once-weekly three-hour lecture which invites scientists, entrepreneurs, and ethicists to speak on a dozen issues at the intersection of modern medicine and organic chemistry. Last year, a few of Harvard’s top scientists, such as stem cell demigod...
...Singapore, points to an expensive array of semiconductors. "We bought that three years ago, so by our standards it's pretty old," he says. "Might be time to get a new one." Says Lane, the Edinburgh expat who moved to Singapore in 2004 to head the Institute of Molecular and Cell Biology: "The funding here is extremely good. You're in scientific heaven...
Former Dean of the Faculty William C. Kirby and the deans of the School of Public Health and the Medical School appointed the 24 members of UPCSE, which was co-chaired by Stubbs, Smith Professor of Molecular Genetics Andrew Murray, and Kuhn Professor of Biological Chemistry and Molecular Pharmacology Christopher Walsh. The three professors are a physicist, biologist, and biochemist, respectively...
...these are just the obvious differences. Not only are clones separated from the original template by time--in Dolly's case, six years--but they are also the product of an unnatural molecular mechanism that turns out not to be very good at making identical copies. In fact, the process can embed small flaws in the genomes of clones that scientists are only now discovering. The more scientists have learned about the inner workings of the procedure that created Dolly, the more they are amazed that she survived...
...Lucentis had yet to gain approval from the Food and Drug Administration. That's why in May 2005 Dr. Philip Rosenfeld, a macular-degeneration specialist in Miami, offered an offbeat solution: he proposed administering a drug with a similar molecular structure,?also made by Genentech, which was already approved by the FDA - for treating colorectal cancer. Since then an estimated 10,000 people worldwide have given the drug, Avastin, a shot - literally - by taking an injection of it in the eye. And most of them have had very good results with the Lucentis cousin...